NYSE:CAH
CARDINAL HEALTH INC
A massive healthcare distributor offering a comprehensive supply chain solution for hospitals and life sciences companies with strong balance sheet efficiency.
Key Metrics
Investment Thesis
Bull Case
Investors may favor Cardinal Health for its dominant market position as the largest healthcare distributor in the US, providing consistent revenue visibility regardless of specific product cycles. The company's ability to generate positive operating cash flow and return capital through dividends and buybacks offers a reliable income stream for shareholders. Strategic acquisitions allow management to integrate new capabilities and expand market share in high-growth segments like home health and surgical services.
Bear Case
The stock faces headwinds from the cyclical nature of healthcare distribution where margins are often thin and heavily dependent on vendor rebates that can fluctuate annually. A significant accumulated deficit in shareholders' equity suggests historical capitalization challenges or aggressive accounting that warrants careful scrutiny of long-term solvency. High levels of debt issuance relative to repayments, combined with negative comprehensive income, indicate potential balance sheet pressure that could limit future financial flexibility.
About CARDINAL HEALTH INC
Cardinal Health Inc. is a leading global healthcare distributor providing medical supplies, pharmaceuticals, and equipment to hospitals, physician offices, and life sciences companies. Operating primarily in the United States with significant international presence, the company leverages its extensive logistics network to deliver essential products to healthcare providers. Key revenue drivers include its broad product portfolio spanning acute care, home health, and surgical services.
Analysis
Management Discussion
Recent financial performance shows revenue growth driven by strategic acquisitions totaling $5.25B, though the current period saw a slight contraction compared to the prior year's peak. Operating cash flow remains robust at $2.40B, supporting significant capital expenditures of $547M and active share repurchases of $765M while managing substantial debt obligations. The company successfully navigated working capital fluctuations with a net change in cash of -$1.26B, reflecting heavy investment activities alongside strong operational earnings.
Industry Overview
The healthcare distribution industry is characterized by high barriers to entry due to the necessity of extensive cold-chain logistics and regulatory compliance requirements. Consolidation continues as smaller distributors struggle with rising operational costs and competition from large-scale players like Cardinal Health and McKesson. Technological adoption is accelerating across the sector, driving demand for suppliers that can offer integrated data solutions alongside traditional supply chain services.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $205.01B | $226.83B | $222.58B |
| Cost of Revenue | $198.12B | $219.41B | $214.41B |
| Gross Profit | $6.89B | $7.41B | $8.17B |
| Operating Expenses | $6.16B | $6.17B | $5.89B |
| Operating Income | $727.0M | $1.24B | $2.27B |
| G&A | $4.83B | $5.00B | $5.38B |
| Stock-Based Comp | $96.0M | $121.0M | $244.0M |
| D&A | $692.0M | $710.0M | $790.0M |
| Depreciation | $441.0M | $470.0M | $488.0M |
| Amortization | $281.0M | $264.0M | $303.0M |
| Other OpEx | $1.33B | $1.17B | $511.0M |
| Non-Operating Income | $-89.0M | $-42.0M | $-174.0M |
| Interest Expense | $93.0M | $51.0M | $215.0M |
| Pre-Tax Income | $638.0M | $1.20B | $2.10B |
| Income Tax | $376.0M | $348.0M | $532.0M |
| Continuing Ops | $262.0M | $853.0M | $1.57B |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $262.0M | $853.0M | $1.57B |
| Minority Interest | $1.0M | $1.0M | $8.0M |
| Net to Common | $261.0M | $852.0M | $1.56B |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Current Assets | $33.83B | $34.88B | $36.37B |
| Cash & Equivalents | $4.04B | $5.13B | $3.87B |
| Marketable Securities | — | $200.0M | — |
| Inventory | $15.94B | $14.96B | $16.83B |
| Other Current Assets | $13.85B | $14.59B | $15.67B |
| Long-Term Assets | $9.58B | $10.24B | $16.75B |
| PP&E (Net) | $2.46B | $2.53B | $2.86B |
| Intangibles | $1.47B | $1.73B | $2.49B |
| Goodwill | $4.61B | $4.72B | $9.69B |
| Operating Leases | $435.0M | $475.0M | $758.0M |
| Other LT Assets | $606.0M | $783.0M | $956.0M |
| Total Assets | $43.42B | $45.12B | $53.12B |
| Current Liabilities | $33.71B | $35.64B | $38.90B |
| Accounts Payable | $29.81B | $31.76B | $34.71B |
| Current Leases | $100.0M | $117.0M | $164.0M |
| Other Current Liab | $3.79B | $3.76B | $4.02B |
| Long-Term Liabilities | $12.56B | $12.69B | $16.86B |
| LT Operating Leases | $375.0M | $400.0M | $654.0M |
| Other LT Liab | $12.19B | $12.29B | $16.20B |
| Total Liabilities | $46.27B | $48.33B | $55.76B |
| Shareholders' Equity | $-2.85B | $-3.21B | $-2.63B |
| Retained Earnings | $-534.0M | $-286.0M | $783.0M |
| AOCI | $-151.0M | $-167.0M | $-155.0M |
| Treasury Stock | $4.91B | $5.68B | $6.37B |
| Total L&E | $43.42B | $45.12B | $53.12B |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Income (CFO) | $262.0M | $853.0M | $1.57B |
| Non-Cash Adjustments | $-2.40B | $771.0M | $-5.16B |
| Working Capital Changes | $4.97B | $2.14B | $5.99B |
| Cash from Operations | $2.84B | $3.76B | $2.40B |
| Capital Expenditures | $481.0M | $511.0M | $547.0M |
| Cash from Investing | $-454.0M | $-1.85B | $-5.59B |
| Debt Issuances | — | $1.14B | $2.90B |
| Debt Repayments | $579.0M | $783.0M | $445.0M |
| Share Buybacks | $2.00B | $750.0M | $765.0M |
| Dividends Paid | $525.0M | $499.0M | $494.0M |
| Cash from Financing | $-3.05B | $-847.0M | $1.94B |
| FX Effect | $-8.0M | $-9.0M | $-3.0M |
| Net Change in Cash | $-674.0M | $1.06B | $-1.26B |
| Beginning Cash | $4.72B | $4.08B | $5.13B |
| Ending Cash | $4.04B | $5.13B | $3.87B |
Frequently Asked Questions
How does CARDINAL HEALTH INC make money?
The company operates through diversified segments including Acute Care (hospital supplies), Home Health (home medical equipment), Surgical Services (surgical instruments and disposables), and Life Sciences (pharmaceuticals and specialty products). Revenue is also generated from Contract Services and other international operations that support its global distribution network.
What are the main risks for CAH?
Regulatory changes in the healthcare sector and drug pricing reforms could impact margins on pharmaceutical distribution businesses. Volatility in foreign exchange rates affects international revenue recognition given the company's global supply chain operations. Rising fuel costs and labor shortages pose ongoing threats to logistics efficiency and operating expense management. Intense competition from other distributors and private label brands may pressure gross profit margins over time.
What is CAH's competitive advantage?
Cardinal Health possesses a massive logistical infrastructure with over 250 facilities globally, enabling rapid delivery of critical medical supplies. Its deep product assortment and long-standing relationships with major pharmaceutical manufacturers provide significant economies of scale and pricing power. The company's investment in technology and data analytics allows for precise inventory management and predictive ordering capabilities.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.